Perrigo Company and its partner Allergan plc announced the launch of guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets, the first OTC store brand equivalent to Mucinex® 1200mg DM extended-release tablets. These products are packaged and marketed as store brands or retailer 'own label' brands and provide consumers a high-quality, value alternative to the Mucinex® 1200mg DM extended-release product.
Mucinex® 1200mg DM extended-release tablets (guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets) are indicated to control coughs and to break up mucus, making coughs more productive.
The Mucinex® 1200mg DM extended-release product produced sales of approximately $108 million through food, drug and mass merchants during the last twelve months.
